| Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. | |
| | |
MedLine Citation:
|
PMID: 15604295 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cisplatin (CDDP) is a highly effective chemotherapeutic agent but with significant ototoxic side effects. Apoptosis is an important mechanism of cochlear hair cell loss following exposure to an ototoxic level of CDDP. This study examines intracellular pathways involved in hair cell death induced by CDDP exposure in vivo to develop effective therapeutic strategies to protect the auditory receptor from CDDP-initiated hearing loss. Guinea pigs were treated with systemic administration of CDDP. Cochlear hair cells from CDDP-treated animals exhibited classic apoptotic alterations in their morphology. Several important signaling events that regulate the death of CDDP-injured cochlear hair cells were identified. CDDP treatment induced the activation and redistribution of cytosolic Bax and the release of cytochrome c from injured mitochondria. Activation of caspase-9 and caspase-3, but not caspase-8, was detected after treatment with CDDP, and the cleavage of fodrin by activated caspase-3 was observed within damaged hair cells. Intracochlear perfusions with caspase-3 inhibitor (z-DEVD-fmk) and caspase-9 inhibitor (z-LEHD-fmk) prevent hearing loss and loss of sensory cells, but caspase-8 inhibitor (z-IETD-fmk) and cathepsin B inhibitor (z-FA-fmk) do not. Although the stress-activated protein kinase/c-Jun NH(2)-terminal kinase (JNK) signaling pathway is activated in response to CDDP toxicity, intracochlear perfusion of d-JNKI-1, a JNK inhibitor, did not protect against CDDP ototoxicity but instead potentiated the ototoxic effects of CDDP. The results of the present study show that blocking a critical step in apoptosis may be a useful strategy to prevent harmful side effects of CDDP ototoxicity in patients having to undergo chemotherapy. |
| | |
Authors:
|
Jing Wang; Sabine Ladrech; Remy Pujol; Philippe Brabet; Thomas R Van De Water; Jean-Luc Puel |
Related Documents
:
|
12917435 - In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degene... 14705865 - Chemical-induced apoptosis: formation of the apaf-1 apoptosome. 18636075 - Cleavage of phospholipase d1 by caspase promotes apoptosis via modulation of the p53-de... 11193035 - A caspase-independent cell clearance program. the lei/l-dnase ii pathway. 8103055 - Modulation of endothelial autacoid release by protein kinase c: feedback inhibition or ... 10092785 - Differential activation of c-jun nh2-terminal kinase and p38 pathways during fty720-ind... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Cancer research Volume: 64 ISSN: 0008-5472 ISO Abbreviation: Cancer Res. Publication Date: 2004 Dec |
Date Detail:
|
Created Date: 2004-12-17 Completed Date: 2005-02-03 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 2984705R Medline TA: Cancer Res Country: United States |
Other Details:
|
Languages: eng Pagination: 9217-24 Citation Subset: IM |
Affiliation:
|
Institut National de la Santé et de la Recherche Medicale-UMR 583 and Université de Montpellier 1, Physiopathologie et thérapie des déficits sensoriels et moteurs, Montpellier, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antineoplastic Agents / toxicity Apoptosis / drug effects Carrier Proteins / metabolism Caspases / antagonists & inhibitors* Cisplatin / toxicity* Cysteine Proteinase Inhibitors / pharmacology* Cytochromes c / metabolism, secretion Female Guinea Pigs Hair Cells, Auditory / drug effects Hearing Loss / chemically induced, enzymology, prevention & control* Isoenzymes JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors* MAP Kinase Signaling System / drug effects Microfilament Proteins / metabolism Mitochondria / drug effects, secretion Proto-Oncogene Proteins c-bcl-2 / metabolism bcl-2-Associated X Protein |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Carrier Proteins; 0/Cysteine Proteinase Inhibitors; 0/Isoenzymes; 0/Microfilament Proteins; 0/Proto-Oncogene Proteins c-bcl-2; 0/bcl-2-Associated X Protein; 0/fodrin; 15663-27-1/Cisplatin; 9007-43-6/Cytochromes c; EC 2.7.11.24/JNK Mitogen-Activated Protein Kinases; EC 3.4.22.-/Caspases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid auto...
Next Document: Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats.